Trial record 3 of 11 for:
arbaclofen autism
An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01064973 |
|
Recruitment Status :
Terminated
(all active subjects were rolled into study 209AS209/NCT01706523)
First Posted : February 9, 2010
Last Update Posted : December 20, 2012
|
Sponsor:
Seaside Therapeutics, Inc.
Information provided by (Responsible Party):
Seaside Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | December 2012 |
| Actual Study Completion Date : | December 2012 |